Old Drugs, New Cures Act
Commerce119-hr2542 — Old Drugs, New Cures Act. Sponsored by Rep. Davis, Donald G. [D-NC-1]. Introduced 2025-04-01. House bill. 119th Congress. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsor
- Rep. Davis, Donald G. [D-NC-1] (D), NC
- Introduced
- 2025-04-01
- Committees
- Ways and Means Committee; Energy and Commerce Committee
- Latest Action
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
No roll-call vote data available for this bill.
Similar Bills
- 114-s426 — Small Business Regulatory Flexibility Improvements Act of 2015 72% match 114th Congress
- 114-hr527 — Providing for consideration of the bill (H.R. 527) to amend chapter 6 of title 5, United States Code (commonly known as the Regulatory Flexibility Act), to ensure complete analysis of potential impacts on small entities of rules, and for other purposes, and providing for consideration of the bill (H.R. 50) to provide for additional safeguards with respect to imposing Federal mandates, and for other purposes. 69% match 114th Congress
- 114-s1536 — Small Business Regulatory Flexibility Improvements Act of 2015 69% match 114th Congress
- 115-hr33 — Regulatory Accountability Act of 2017 69% match 115th Congress
- 115-s584 — Regulatory Accountability Act of 2017 65% match 115th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis